Skip to main content

Security report for angelini.at

Angelini Pharma Österreich GmbH · Healthcare · Austria

Medium risk. 3 critical or high findings in GDPR outside view and SSL/TLS.

Security score

64/100

Risk levelMedium

0–100, higher is better. How it is calculated

Angelini Pharma Österreich GmbH operates as a pharmaceutical company specializing in brain health, oncology, pain management, and consumer health products. The company is part of the larger Angelini S.p.a. group and maintains a strong market presence in Austria and several European countries. Their website reflects a professional and consistent brand image, targeting healthcare professionals and consumers with comprehensive product and research information. Technically, the website employs modern JavaScript libraries such as jQuery, Slick Slider, and Piwik PRO for analytics, combined with a consent management platform to ensure GDPR compliance. The site is mobile-optimized and structured for good SEO and accessibility, although some accessibility features could be enhanced. From a security perspective, the site enforces HTTPS and uses privacy-conscious analytics with anonymization options. However, it lacks explicit security headers and a published security policy or incident response contact, which are recommended for improved security posture. No critical vulnerabilities or exposed sensitive data were detected. Overall, the website demonstrates a mature digital presence with strong privacy compliance and business credibility. Strategic improvements in security headers and incident response transparency would further enhance trust and resilience.

Scanned

NIS2 and GDPR posture

GDPR outside view
55/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

3 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      No HTTPS encryption

      GDPR requires appropriate security measures for personal data

      What to do: Implement SSL/TLS certificate for HTTPS

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • Critical

      No HTTPS Encryption

      Website does not use HTTPS encryption, making all data transmission vulnerable to interception

      What to do: Implement SSL/TLS certificate and redirect all HTTP traffic to HTTPS

Need hands-on remediation? Email guard@offseq.com

Keep watching angelini.at

This scan found 15 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
0
Security headers
90
Email security
60
DNS health
80
Network security
100
GDPR outside view
55
Average
64

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Angelini Pharma is positioned as a medium-sized pharmaceutical company with a focus on innovative healthcare solutions, particularly in brain health and oncology. Their business model revolves around pharmaceutical product development, research collaborations, and healthcare education. The company benefits from its affiliation with Angelini S.p.a., providing a broad European footprint through multiple subsidiary domains. The website content and certifications indicate a commitment to quality and employee well-being, enhancing their competitive advantage. Their target customers include healthcare professionals and patients, supported by active social media engagement and comprehensive news updates. Growth indicators include ongoing research initiatives, partnerships, and participation in healthcare awareness campaigns. The company maintains a transparent and professional online presence, which supports its market credibility and customer trust.

Security posture

The website exhibits a solid security foundation with enforced HTTPS and a cookie consent mechanism aligned with GDPR requirements. The use of Piwik PRO analytics with anonymization options reflects a privacy-conscious approach. However, the absence of key security headers such as Content-Security-Policy, X-Frame-Options, and Strict-Transport-Security represents an area for improvement. No incident response or security contact information is publicly available, which could hinder timely vulnerability reporting and response. No signs of malware, phishing, or exposed credentials were found. The third-party libraries used are standard and widely adopted, but continuous monitoring for vulnerabilities is advised. Overall, the security posture is good but could be elevated with enhanced header configurations and published security policies.

Recommendations

  1. Implement comprehensive security headers including Content-Security-Policy, X-Frame-Options, and Strict-Transport-Security.
  2. Publish a dedicated security policy page and provide clear incident response contact channels.
  3. Regularly audit and update third-party libraries to mitigate potential vulnerabilities.
  4. Enhance accessibility features to improve compliance with WCAG standards.
  5. Maintain transparency in data retention policies and update privacy notices accordingly.

Contact details published on the site

Addresses
Legal name
Angelini Pharma Österreich GmbH
VAT number
ATU45393408
Registration number
FN 173570a
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Angelini Pharma Österreich GmbH
Description
Angelini Pharma Österreich GmbH is a pharmaceutical company focused on brain health, oncology, pain, and consumer health sectors. They provide pharmaceutical products and engage in research and development, emphasizing innovation and cooperation in the healthcare field.
Key services
Pharmaceutical product development, Research and innovation, Healthcare education and initiatives
Content quality
good
Branding
consistent

Technology

Stack
jQuery, jQuery Validation, Slick Slider, Magnific Popup, Piwik PRO Analytics, Flip.js
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Consent management platform for cookies
  • No exposed sensitive data in HTML
  • Use of analytics with anonymization options

Analytics and tracking

Services
Piwik PRO
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Piwik PRO
Marketing tools
Piwik PRO Consent Management
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is professionally designed and well-structured.
  2. Content is comprehensive and relevant to pharmaceutical and healthcare sectors.
  3. Strong presence of privacy and cookie policies with consent management.
  4. Use of modern JavaScript libraries and analytics tools with privacy considerations.
  5. No signs of blocking or WAF interference.
  6. Social media presence across major platforms enhances trust.
  7. Certifications and awards displayed add credibility.
  8. No exposed sensitive data or obvious security vulnerabilities detected.
Technical notes

Notes

The website uses a modern front-end stack with jQuery and popular plugins for sliders and popups, ensuring interactive and responsive user experience. Analytics are handled via Piwik PRO with asynchronous loading and consent management integration, supporting privacy compliance. The site is hosted on a custom domain with no detected CMS, indicating a bespoke or enterprise solution. Performance is moderate, with room for optimization in loading times and accessibility. The site is mobile-optimized and SEO-friendly, with proper meta tags and Open Graph data. Technical debt appears low, but the lack of some security headers and accessibility enhancements suggests areas for modernization.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with angelini.at. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review angelini.at.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.